Clinical Trial: An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680205) titled 'An Experimental Study of Belzutifan Impact on Catecholamine Metabolism' on June 23.

Brief Summary: To investigate the impact of a medication called Belzutifan on the production and subsequent metabolism of adrenaline and noradrenaline collectively termed 'catecholamines'. The study aims to identify changes in the production and metabolism of catecholamines by measuring the substance which starts the chain of catecholamine metabolism called tyrosine in patients before, during and after 5 days of taking Belzutifan 120mg daily.

Study Start Date: April 27

Study Type: INTERVENTIONAL

Condition: Pheochromocytoma and Paraganglioma (PPGL)...